Active vitamin D supplementation and COVID-19 infections: review

被引:0
作者
Nakhoul Farid
Nakhoul Rola
Elias A. T. Koch
Nakhoul Nakhoul
机构
[1] Baruch Padeh Poriya medical Center,Nephrology and Hypertension Division
[2] Baruch Padeh Poriya Medical Center,Diabetes and Metabolism Lab
[3] Bar Ilan University,Azrieli Faculty of Medicine
[4] University Hospital Erlangen,Department of Anaesthesiology
[5] University Hospital Erlangen,Department of Dermatology
[6] Baruch Padeh Poriya Medical Center,Ophtalmology Division
来源
Irish Journal of Medical Science (1971 -) | 2021年 / 190卷
关键词
Angiotensin converting enzyme 2; COVID-19; Renin; SARS-CoV-2; Vitamin D;
D O I
暂无
中图分类号
学科分类号
摘要
SARS-CoV-2, causing the lethal disease COVid-19, is a public health emergency in the 2020 global pandemic. The outbreak and fast spreading of SARS-CoV-2 have a high morbidity and mortality specifically in elder patients with chronic diseases such as diabetes mellitus, arterial hypertension, chronic kidney disease, and organ transplanted patients with immunosuppressive therapy. Preliminary results support different treatments such as chloroquine and convalescent plasma infusion in severe cases, with good outcome. On the other hand, the efficacy of supplementation with active vitamin D, an immunomodulator hormone with antiinflammatory and antimicrobial effects, is unproven. A recent study reported that vitamin D attains antiviral effects, via blocking viral replication directly. SARS-CoV-2 primarily uses the immune evasion process during infection via the envelope spike glycoprotein, which is followed by a cytokine storm, causing severe acute respiratory disease syndrome and death. SARS-CoV-2, by using the well-known angiotensin-converting enzyme 2 by the protein spike, as the host receptor to enter into alveolar, myocardial, and renal epithelial cells, can be disrupted by vitamin D. However, the correlation between vitamin D levels and COVID-19 deaths in previous studies was insignificant. Retrospective studies demonstrated a correlation between vitamin D status and COVID-19 severity and mortality, while other studies did not find this correlation. Studies have shown that, vitamin D reduces the risk of acute viral respiratory tract infections and pneumonia via direct inhibition of viral replication, antiinflammatory and immunomodulatory effects. The data available today regarding the beneficial protective effect of vitamin D is unclear and with conflicting results. Large randomized control trials are necessary to test this hypothesis. In this review, we will explain the cross talk between the active vitamin D and the angiotensin-converting enzyme 2, and summarize the data from the literature.
引用
收藏
页码:1271 / 1274
页数:3
相关论文
共 60 条
[1]  
Singhal T(2020)A review of Coronavirus Disease-2019 (COVID-19) Indian J Pediatr 87 281-286
[2]  
Sifuentes-Rodríguez E(2020)COVID-19: the outbreak caused by a new coronavirus Bol Med Hosp Infant Mex 77 47-53
[3]  
Palacios-Reyes D(2020)The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak J Autoimmun 109 102433-1205
[4]  
Rothan HA(2015)Vitamin D bioavailability: state of the art Crit Rev Food Sci Nutr 55 1193-3021
[5]  
Byrareddy SN(2020)Vitamin-D and COVID-19: do deficient risk a poorer outcome? Lancet Diabetes Endocrinol. 8 570-492
[6]  
Borel P(2015)Vitamin D and 1,25(OH)2D regulation of T cells Nutrients 7 3011-2448
[7]  
Caillaud D(2014)Impact of vitamin D on immune function: lessons learned from genome-wide analysis Front. Physiol. 5 151-2011
[8]  
Cano NJ(2013)ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis Br J Pharmacol. 169 477-128
[9]  
Mitchell F(2020)Renin–angiotensin–aldosterone system inhibitors and risk of Covid-19 N Engl J Med. 382 2441-21
[10]  
Cantorna MT(2020)COVID-19 (Novel Coronavirus 2019) - recent trend, review Eur Rev Med Pharmacol Sci. 24 2006-7